Interleukin 23 inhibition associates with lower incidence of cardiovascular risk factor type diseases compared with biologicnaıve patients with psoriasis: A retrospective cohort study Letter

sustainable development goals

publication date

  • January 17, 2025

webpage

published in

keywords

  • MACEs
  • biologics
  • cardiovascular risk
  • diabetes
  • dyslipidemia
  • hypertension
  • incidence
  • inflammatory
  • psoriasis
  • psoriasis therapy

start page

  • 337

end page

  • 340

volume

  • 92

issue

  • 2